First-to-market platform provides actionable risk scores and personalized interventions for common pregnancy complications.
Prenome equips professionals with the tools to provide personalized care to better the lives of their patients.
Prenome's OneinSeven is a research study, examining the genetic and lifestyle risk factors associated with gestational diabetes. This study will generate proprietary polygenic risk scores (PRS) that calculate the risk of development of gestational diabetes in pregnant persons based on their genetic profile and sociodemographic information.Learn More
Our team of women's health professionals, scientists, and esteemed advisors work to create accessible high-tech high-touch preventive care to improve women's health conditions.Learn More